Argitalpenak (38) Ikertzaileren baten partaidetza izan duten argitalpenak

2024

  1. Combined HRAS and NRAS ablation induces a RASopathy phenotype in mice

    Cell Communication and Signaling, Vol. 22, Núm. 1

  2. Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury

    Spinal Cord, Vol. 62, Núm. 8, pp. 454-467

2023

  1. Advances in Molecular Research of Oncogenes

    International Journal of Molecular Sciences

  2. Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors

    Oncogene, Vol. 42, Núm. 5, pp. 389-405

  3. Critical requirement of SOS1 for tumor development and microenvironment modulation in KRASG12D-driven lung adenocarcinoma

    Nature Communications, Vol. 14, Núm. 1

  4. GRF2 Is Crucial for Cone Photoreceptor Viability and Ribbon Synapse Formation in the Mouse Retina

    Cells, Vol. 12, Núm. 21

  5. Optimized Protocol for Isolation and Culture of Murine Neonatal Primary Lung Fibroblasts

    Methods and Protocols, Vol. 6, Núm. 1

  6. PKD phosphorylation and COP9/Signalosome modulate intracellular Spry2 protein stability

    Oncogenesis, Vol. 12, Núm. 1

  7. Unveiling the Mysteries of RAS Signaling: A Journey of Discovery and Breakthroughs

    Genes

2022

  1. Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia

    Cancers, Vol. 14, Núm. 16

2021

  1. 40 years of RAS-a historic overview

    Genes, Vol. 12, Núm. 5

  2. Anthraquinones as inhibitors of SOS RAS-GEF activity

    Biomolecules, Vol. 11, Núm. 8

  3. Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism, and redox homeostasis

    Oncogene, Vol. 40, Núm. 27, pp. 4538-4551

  4. Functional specificity of the members of the sos family of ras‐gef activators: Novel role of sos2 in control of epidermal stem cell homeostasis

    Cancers, Vol. 13, Núm. 9

  5. Ras GEF Mouse Models for the Analysis of Ras Biology and Signaling

    Methods in Molecular Biology (Humana Press Inc.), pp. 361-395

  6. Sos2 comes to the fore: Differential functionalities in physiology and pathology

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

  7. The Crossroads between RAS and RHO Signaling Pathways in Cellular Transformation, Motility and Contraction

    Genes, Vol. 12, Núm. 6

  8. The childhood-onset neurodegeneration with cerebellar atrophy (Condca) disease caused by agtpbp1 gene mutations: The purkinje cell degeneration mouse as an animal model for the study of this human disease

    Biomedicines, Vol. 9, Núm. 9

  9. The importance of being PI3K in the RAS signaling network

    Genes, Vol. 12, Núm. 7

  10. The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriers

    Acta Pharmaceutica Sinica B, Vol. 11, Núm. 8, pp. 2243-2264